CTRI/2024/04/065522尚未招募Unknown
Study of the efficacy and safety of Dolutegravir based first line anti-retroviral Therapy in people living with HIV infection. - NI
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Minimum 1000 patients for retrospective and prospective studies with confirmed and documented HIV1 infection on Dolutegravir, Lamivudine and Tenofovir Alafenamide
排除标准
- •Patients on 2nd, 3rd, other regimens and patients not giving consent to the study
研究者
相似试验
招募中
2 期
Evaluation of the effect of an antiretroviral drug in patients infected with HTLV-1.Human T-lymphotropic virus 1B04RBR-5x7ccxpFundação Bahiana de Infectologia - FBA
招募中
不适用
Evaluation of use of Dolutegravir in children aged 6 to 12 years: a multicenter study in BrazilHuman immunodeficiency virus (HIV) disease resulting in infectious and parasitic diseasesRBR-87x8h69Faculdade de Medicina, Universidade Federal de Minas Gerais/UFMG
招募中
4 期
Safety and efficacy of Dolutegravir and EFV400 for pregnant and breastfeeding women: a randomized non-inferiority clinical trialHIV/AIDSPACTR201909810587438Hawassa University1,830
招募中
3 期
Evaluation of the Efficacy and safety of dolutegravir in patients with moderate COVID-19 diseaseIRCT20200328046886N3Mazandaran University of Medical Sciences100
尚未招募
Unknown
In vivo Bioequivalence study of Dolutegravir tabletsIRCT20220211053992N36Tabriz University of Medical Sciences24